Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardiac Gene Therapy: Combination Products' Next Frontier?

This article was originally published in Start Up

Executive Summary

Orthopedic biomaterials and drug-eluting stents are only the first hint at the potentially transforming nature of combination products: device/biologic combination products that may bring a revolution to clinical therapy and to the device industry. In vascular medicine, catheter-based delivery of cardiac gene therapy may become a significant advance, yet with scant clinical evidence of efficacy and only anecdotal physician experience using catheter delivery systems, the field remains all promise. Many device executives think they see a path emerging, largely due to fundamental changes in the dynamics of their industry that are moving device business models closer to that of their pharma industry cousins.
Advertisement

Related Content

In Cardiac Regeneration, it's Repair, not Replace
Convergence: What's Next at the Nexus?
After Drug-Eluting Stents: Making the Heart Smaller and the Market Larger
Medtronic and Genzyme Combine Their Cell Therapy Approaches to Serious Heart Disease
Convergence and Complexity in Cardiac Regeneration
Convergent Calling: An Interview with Medtronic's Stephen Oesterle
Edwards: Will a Biotech Deal Strategy Work For a Device Company?
Gene Delivery: Looking Past the Skeptics
Gene Therapy Trials and Tribulations
The Device Angle on Angiogenesis

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090795

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel